HRSA Publishes Notice Contemplating Expanding 340B Rebate Model to 13 Manufacturers and Extends Rebate RFI Comment Deadline

2/27/2026 – HRSA Publishes Notice Contemplating Expanding 340B Rebate Model to 13 Manufacturers and Extends Rebate RFI Comment Deadline HRSA published two Federal Register Notices (FRNs) about another potential 340B…

HRSA Seeks Information from Stakeholders on Another Potential 340B Rebate Model

2/17/2026 – HRSA Seeks Information from Stakeholders on Another Potential 340B Rebate Model HRSA has released a request for information (RFI) seeking input on a possible 340B rebate program. The RFI is…

In a Victory for Covered Entities, Fifth Circuit Upholds Louisiana’s 340B Contract Pharmacy Protection Law

2/11/2026 – In a Victory for Covered Entities, Fifth Circuit Upholds Louisiana’s 340B Contract Pharmacy Protection Law In a consolidated decision involving AbbVie, AstraZeneca, and the Pharmaceutical Research and Manufacturers of America…

HRSA Takes Steps to Pursue New 340B Rebate Model

2/11/2026 – HRSA Takes Steps to Pursue New 340B Rebate Model HRSA announced its intention to pursue a new 340B rebate model last week through submission of a “Prerule” regarding…

Trump’s Online Marketplace for Direct-to-Consumer Drugs is Now Live, and Could Impact 340B

2/10/2026 – Trump’s Online Marketplace for Direct-to-Consumer Drugs is Now Live, and Could Impact 340B Last week, HHS launched its website TrumpRx.gov which the Administration says is intended to “facilitate direct-to-consumer purchasing…

CMS Announces Drugs Subject to IRA Negotiated Prices Starting in 2028

1/30/2026 CMS Announces Drugs Subject to IRA Negotiated Prices Starting in 2028 Please click on the link below: CMS Announces Drugs Subject to IRA Negotiated Prices Starting in 2028 Powers…